Engineered IgM Antibody Administered Intranasally May Be More Potent at Inhibiting SARS-CoV-2 ...

Retrieved on: 2021-06-10 10:18:45

Tags for this article:

Click the tags to see associated articles and topics

Engineered IgM Antibody Administered Intranasally May Be More Potent at Inhibiting SARS-CoV-2 .... View article details on hiswai:

Excerpt

An IgM version of an anti-SARS-CoV-2 IgG monoclonal antibody is being developed as an intranasally administered agent for the treatment and ...

Article found on: www.hospimedica.com